NPI registry status
Active
2026 NPPES data Medical Biochemical Genetics NPI 1689835209 M.D.
Verify on CMS → Michelle Polan, M.D.
Medical Biochemical Genetics in Tulsa, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 21 in Medical Biochemical Genetics, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
63
Medicare Part D claims · Medical Biochemical Genetics avg: 29
Generic prescribing
33%
generic claims · 67% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
77.7/100
▼ 5 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michelle Polan, M.D. reported a CMS MIPS final score of 77.7/100 - below the 83.1 national average - and filed 63 Medicare Part D claims in 2023.
- 77.7/100
- MIPS score · -5 vs avg
- 63
- Part D claims, 2023
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michelle Polan, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
78 24th percentile higher than 24% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
✓
Board certification likely (heuristic, not verified)
Michelle Polan, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michelle Polan, M.D.?
Below national averagePrimary specialty
Medical Biochemical Genetics
Medicare Part D claims
63 117% vs specialty avg
MIPS final score
77.7/100 5.4 pts vs avg
Specialty distribution in Oklahoma
How Medical Biochemical Genetics compares to other specialties among Oklahoma providers
Medicare quality performance, MIPS
Michelle Polan, M.D.'s 2023 MIPS final score plotted against the Medical Biochemical Genetics national average
- MIPS Final Score
- 77.7/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Biochemical Genetics) - 77.7/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michelle Polan, M.D. appears in the CMS NPPES registry as a Medical Biochemical Genetics provider holding M.D. credentials at 9820 E 41ST ST STE 301, Tulsa, OK, 74146, with a listed phone of (405) 862-7850. NPI 1689835209 was issued on 06/17/2008.
Medicare Part D records for calendar year 2023 show 63 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $1.6 million in drug spend, split 67% brand-name and 33% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 77.7/100 for the 2023 performance year (Quality 82.5, Cost 43.1), compared with the national average of 83.1.
Medical Biochemical Genetics is a narrow specialty nationwide, with 21 enrolled providers across 13 states and an average of 29 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1689835209 |
|---|---|
| Specialty | Medical Biochemical Genetics |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/17/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
77.6983
Final Score
Avg: 83.1
82.5298
Quality
43.1313
Cost
100
Promoting Interoperability
Reporting: Group practice
Brand vs generic prescribing mix · Brand-heavy
Michelle Polan, M.D. - brand share 67.0%
Medical Biochemical Genetics average
67% brand-name claims vs 33% generic, on 63 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
63
Total Claims
$1.6M
Total Drug Cost
N/A
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 63
- Total Day Supply
- 1,803
- Brand vs Generic
- 67% brand / 33% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $363K
Patient Demographics
- Average Patient Age
- 57.5 years
- Avg HCC Risk Score
- 1.05
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Palynziq Pegvaliase-Pqpz | 34 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Biochemical Genetics Overview
How Michelle Polan, M.D. fits within the Medical Biochemical Genetics landscape nationally.
21
Medical Biochemical Genetics Providers in US
13
States with Medical Biochemical Genetics
29
Avg Claims per Provider
Michelle Polan, M.D.'s 63 claims are above the specialty average of 29.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Oklahoma medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Biochemical Genetics peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Oklahoma
Frequently Asked Questions
What is Michelle Polan, M.D.'s specialty? ▼
Michelle Polan, M.D. specializes in Medical Biochemical Genetics and practices in Tulsa, Oklahoma. Credentials: M.D..
How much does Michelle Polan, M.D. prescribe under Medicare Part D? ▼
In 2023, Michelle Polan, M.D. wrote 63 Medicare Part D claims totaling $1.6M in drug costs for N/A beneficiaries.
What is Michelle Polan, M.D.'s Medicare quality score? ▼
Michelle Polan, M.D. has a CMS MIPS Final Score of 77.7/100 (Quality: 82.5, Cost: 43.1). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michelle Polan, M.D. located? ▼
Michelle Polan, M.D. is located at 9820 E 41ST ST STE 301, Tulsa, OK, 74146. Phone: (405) 862-7850.
What is Michelle Polan, M.D.'s NPI number? ▼
Michelle Polan, M.D.'s National Provider Identifier (NPI) is 1689835209, issued on 06/17/2008.
Does Michelle Polan, M.D. prescribe more brand-name or generic drugs? ▼
Michelle Polan, M.D.'s prescribing is 67% brand-name and 33% generic drugs by claim count, with $1.2M in brand drug costs.
How many Medical Biochemical Genetics providers are there in the US? ▼
There are 21 Medical Biochemical Genetics providers across 13 states in the US. The average Medical Biochemical Genetics provider writes 29 Medicare Part D claims per year.
What drugs does Michelle Polan, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michelle Polan, M.D.'s most frequently prescribed drugs include Palynziq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michelle Polan, M.D. accept Medicare? ▼
Michelle Polan, M.D. appears in CMS Medicare data with 63 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michelle Polan, M.D.'s credentials? ▼
Michelle Polan, M.D.'s NPI is 1689835209 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.